DataVXJournal of Nanoparticle ResearchPaper
journal article·2023-07

Trends in the use of montmorillonite as a delivery system for active substances

Igor Eduardo Silva Arruda, Jabson Herber Profito de Oliveira, Bolivar Ponciano Goulart de Lima Damasceno, Mônica Felts de La Roca Soares, Dayanne Tomaz Casimiro da Silva, José Lamartine Soares-Sobrinho

Journal of Nanoparticle Research· Volume 25· Issue 7
Publisher page
Source abstract

Abstract

The use of montmorillonite has been investigated as a delivery system for active substances and few studies report discussions and visualization of publications on this topic. Thus, the objective of this study is to explore related research fields from a bibliometric perspective, characterize current trends, and present visual representations of the last decades. In this study, the analysis of the publications was performed using the RStudio v.1.3.959 software and the R programming language from the Bibliometrix package. A total of 778 articles were analyzed. From 1976 to 2023, there was a tendency for publications to grow, with an increase of 217.39% in 10 years. China (195 publications and 4297 citations) and Nir S. (18 publications, 744 citations, 5 articles as last author) were the most productive and impactful country and author, respectively. The co-occurrence cluster analysis of the 50 keywords form clusters with “montmorillonite,” “adsorption,” and “controlled release” and clusters “nanoparticles,” “delivery,” and “nanocomposites,” which were the most used keywords. In a coupling cluster analysis, publications using montmorillonite with drugs achieved a much greater publishing impact than with other materials. Trends in publications allocate montmorillonite for the release of active substances considering the state of ionization, pH, modification by inclusion of organic compounds, water displacement, change in interlamellar characteristics, use of chitosan, and alginate forming nanocomposites, microsphere, granules, nanoparticles, and adsorption, the last three being the most impactful. In this way a multifaceted material has composed formulations of substance delivery system. Graphical Abstract
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

Nanomaterials

OpenAlex topics: Therapeutic Uses of Natural Elements · Clay minerals and soil interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. López-Galindo A, Viseras C, Cerezo P (2007) Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products. Appl Clay Sci 36(1–3):51–63. https://doi.org/10.1016/j.clay.2006.06.01610.1016/j.clay.2006.06.016 ↗
2. Guggenheim S, Martin RT, Alietti A, Drits VA, Formoso MLL, Galán E, Wicks FJ (1995) Definition of clay and clay mineral: joint report of the AIPEA nomenclature and CMS nomenclature committees. Clays Clay Miner 43(2):255–256. https://doi.org/10.1346/CCMN.1995.043021310.1346/CCMN.1995.0430213 ↗
3. Viseras C, Carazo E, Borrego-Sánchez A, García-Villén F, Sánchez-Espejo R, Cerezo P, Aguzzi C (2019) Clay minerals in skin drug delivery. Clays Clay Miner 67(1):59–71. https://doi.org/10.1007/s42860-018-0003-710.1007/s42860-018-0003-7 ↗
4. López-Galindo A, Viseras C (2004) Pharmaceutical and cosmetic applications of clays. In Clay surfaces: fundamentals and applications (1st ed., Vol. 1, pp. 268–289)10.1016/S1573-4285(04)80044-9 ↗
5. USP United States Pharmacopeial Convention (2019) The United States pharmacopeia USP42, the national formulary NF37/United States Pharmacopeial Convention. In The United States pharmacopeia USP42, the national formulary NF37 / United States Pharmacopeial Convention (First edition., Vol. 7). Rockville, Maryland: United States Pharmacopeial Convention
6. Rowe R (2009) Handbook of pharmaceutical excipients. In Raymond C Rowe, Paul J Sheskey, & Marian E Quinn (Eds.), Handbook of pharmaceutical excipients (6th ed., Vol. 6, pp. 0–917). London
7. Iborra CV, Cultrone G, Cerezo P, Aguzzi C, Baschini MT, Vallés J, López-Galindo A (2006) Characterisation of northern Patagonian bentonites for pharmaceutical uses. Appl Clay Sci 31(3–4):272–281. https://doi.org/10.1016/j.clay.2005.11.00210.1016/j.clay.2005.11.002 ↗
8. Hacıosmanoğlu GG, Mejías C, Martín J, Santos JL, Aparicio I, Alonso E (2022) Antibiotic adsorption by natural and modified clay minerals as designer adsorbents for wastewater treatment: a comprehensive review. J Environ Manag 317. https://doi.org/10.1016/j.jenvman.2022.11539710.1016/j.jenvman.2022.115397 ↗
9. Brigatti MF, Galan E, Theng BKG (2006) Structure and mineralogy of clay minerals, In: Bergaya, F., Lagaly, G. (Eds.), Chapter 2 in the Handbook of clay science, 2nd ed. (Elsevier Ltd., Ed.) (1st ed., Vol. 1). https://doi.org/10.1016/B978-0-08-098258-8.09989-210.1016/B978-0-08-098258-8.09989-2 ↗
10. Silva DTC, Arruda IES, França LM, França DB, Fonseca MG, Soares MFLR, … Soares-Sobrinho JL (2019) Tamoxifen/montmorillonite system – effect of the experimental conditions. Appl Clay Sci 180(September 2018):105142. https://doi.org/10.1016/j.clay.2019.10514210.1016/j.clay.2019.105142 ↗
11. del Mar Orta M, Martín J, Medina-Carrasco S, Santos JL, Aparicio I (2019) Alonso E (2019) Adsorption of propranolol onto montmorillonite: kinetic, isotherm and pH studies. Appl Clay Sci 173(July 2018):107–114. https://doi.org/10.1016/j.clay.2019.03.01510.1016/j.clay.2019.03.015 ↗
12. Krupskaya V, Novikova L, Tyupina E, Belousov P, Dorzhieva O, Zakusin S, … Belchinskaya L (2019) The influence of acid modification on the structure of montmorillonites and surface properties of bentonites. Appl Clay Sci 172(February):1–10. https://doi.org/10.1016/j.clay.2019.02.00110.1016/j.clay.2019.02.001 ↗
13. Silva DTC, Fonseca MG, Borrego-sánchez A, Soares MFR, Viseras C, Sainz-díaz CI, Sobrinho JLS (2020) Adsorption of tamoxifen on montmorillonite surface. Microporous Mesoporous Mater 110012. https://doi.org/10.1016/j.micromeso.2020.11001210.1016/j.micromeso.2020.110012 ↗
14. Borrego-Sánchez A, Carazo E, Aguzzi C, Viseras C, Sainz-Díaz CI (2018) Biopharmaceutical improvement of praziquantel by interaction with montmorillonite and sepiolite. Appl Clay Sci 160(October 2017):173–179. https://doi.org/10.1016/j.clay.2017.12.02410.1016/j.clay.2017.12.024 ↗
15. Stoch L (1990) Chemical reactions of clay minerals and their utilization. Sci Geol Mém 89:111–120
16. Bergaya F, Lagaly G (2006) Chapter 1 General introduction: clays, clay minerals, and clay science. Dev Clay Sci1(C):1–18. https://doi.org/10.1016/S1572-4352(05)01001-910.1016/S1572-4352(05)01001-9 ↗
17. Jayrajsinh S, Shankar G, Agrawal YK, Bakre L (2017) Montmorillonite nanoclay as a multifaceted drug-delivery carrier: a review. J Drug Deliv Sci Technol 39:200–209. https://doi.org/10.1016/j.jddst.2017.03.02310.1016/j.jddst.2017.03.023 ↗
18. Wicklein B (2011) Bio-nanohybrid materials based on clays and phospholipids (Thesis). Instituto de Ciencia de Materiales de Madrid, Madrid
19. Uddin F (2018) Montmorillonite: an introduction to properties and utilization. In Current topics in the utilization of clay in industrial and medical applications (1st ed., Vol. 1, pp. 3–24). InTech. https://doi.org/10.5772/intechopen.7798710.5772/intechopen.77987 ↗
20. Liu JH, Cai WK, Khatoon N, Yu WH, Zhou CH (2021) On how montmorillonite as an ingredient in animal feed functions. Appl Clay Sci 202:0–105963. https://doi.org/10.1016/j.clay.2020.10596310.1016/j.clay.2020.105963 ↗
21. Farahat MM, Abdel Khalek MA, Sanad MMS (2022) Affordable and reliable cationic-anionic magnetic adsorbent: processing, characterization, and heavy metals removal. J Clean Prod 360. https://doi.org/10.1016/j.jclepro.2022.13217810.1016/j.jclepro.2022.132178 ↗
22. Mohammad-Rezaei R, Khalilzadeh B, Rahimi F, Moradi S, Shahlaei M, Derakhshankhah H, Jaymand M (2022) Simultaneous removal of cationic and anionic dyes from simulated industrial effluents using a nature-inspired adsorbent. Environ Res 214. https://doi.org/10.1016/j.envres.2022.11396610.1016/j.envres.2022.113966 ↗
23. Shattar SFA, Zakaria NA, Foo KY (2019) Preparation of a montmorillonite-derived adsorbent for the practical treatment of ionic and nonionic pesticides. J Market Res 8(5):4713–4724. https://doi.org/10.1016/j.jmrt.2019.08.01710.1016/j.jmrt.2019.08.017 ↗
24. Wang F, Pan F, Li G, Zhang P, Wang N (2021) Construction of spherical montmorillonite supported Cu-based catalyst doping with a covalent organic framework for 4-nitrophenol removal. Appl Clay Sci 214. https://doi.org/10.1016/j.clay.2021.10627810.1016/j.clay.2021.106278 ↗
25. Wadhawa GC, Valvi AK, Mohite RD, Patil DD, Patil B, Gavit HJ (2022) An Organo-Heterogeneous catalyst for synthesis of benzimidazole derivatives using nanoparticles synthesized from Plant extract and supported on Montmorillonite K10. Mater Today: Proc 58:764–768. https://doi.org/10.1016/j.matpr.2022.03.10010.1016/j.matpr.2022.03.100 ↗
26. Al Kausor M, Sen Gupta S, Bhattacharyya KG, Chakrabortty D (2022) Montmorillonite and modified montmorillonite as adsorbents for removal of water soluble organic dyes: a review on current status of the art. Inorg Chem Commun 143:0–109686. https://doi.org/10.1016/j.inoche.2022.10968610.1016/j.inoche.2022.109686 ↗
27. Mohan C, Kumari N (2022) Synthesis of acid activated and silicotungstic acid (STA) intercalated montmorillonite clay as green catalyst. Mater Today: Proc 56:971–975. https://doi.org/10.1016/j.matpr.2022.03.09310.1016/j.matpr.2022.03.093 ↗
28. Wang G, Ding C, Liu N, Liu H, Yang J, Ma S, … Zhao H (2022) Complexant-montmorillonite nanocomposites for heavy metal binding in sulfide tailing. J Mater Res Technol 17:329–341. https://doi.org/10.1016/j.jmrt.2022.01.01910.1016/j.jmrt.2022.01.019 ↗
29. Zhang H, Jiang L, Wang H, Li Y, Chen J, Li J, … Xiong T (2022) Evaluating the remediation potential of MgFe2O4-montmorillonite and its co-application with biochar on heavy metal-contaminated soils. Chemosphere 299. https://doi.org/10.1016/j.chemosphere.2022.13421710.1016/j.chemosphere.2022.134217 ↗
30. Zhang, Z, Huang Y, Zhu Z, Yu M, Gu L, Wang X, … Wang R (2022) Effect of CaO and montmorillonite additive on heavy metals behavior and environmental risk during sludge combustion. Environ Pollut 120024. https://doi.org/10.1016/j.envpol.2022.12002410.1016/j.envpol.2022.120024 ↗
31. Ma J, Khan MA, Xia M, Fu C, Zhu S, Chu Y, … Wang F (2019) Effective adsorption of heavy metal ions by sodium lignosulfonate reformed montmorillonite. Int J Biol Macromol 138:188–197. https://doi.org/10.1016/j.ijbiomac.2019.07.07510.1016/j.ijbiomac.2019.07.075 ↗
32. Xiao H, Wang G, Liang G, Zhu J, Qiu J, Ding C, Komarneni S (2022) Stabilization of heavy metals from lead-zinc ore tailings with sodium diethyl dithiocarbamate functionalized montmorillonite (DDTC-Mt): leaching characteristics and remediating mechanism. Miner Eng 183. https://doi.org/10.1016/j.mineng.2022.10760810.1016/j.mineng.2022.107608 ↗
33. Horue M, Cacicedo ML, Fernandez MA, Rodenak-Kladniew B, Torres Sánchez RM, Castro GR (2020) Antimicrobial activities of bacterial cellulose – silver montmorillonite nanocomposites for wound healing. Mater Sci Eng C:116. https://doi.org/10.1016/j.msec.2020.11115210.1016/j.msec.2020.111152 ↗
34. Oliveira LH, Trigueiro P, Souza JSN, Carvalho MS, Osajima JA, Silva-Filho EC, Fonseca MG (2022) Montmorillonite with essential oils as antimicrobial agents, packaging, repellents, and insecticides: an overview. Colloids Surf B: Biointerfaces 209:0–112186. https://doi.org/10.1016/j.colsurfb.2021.11218610.1016/j.colsurfb.2021.112186 ↗
35. Xu P, Hong F, Wang J, Cong Y, Dai S, Wang S, … Zhai Y (2017) Microbiome remodeling via the montmorillonite adsorption-excretion axis prevents obesity-related metabolic disorders. EBioMedicine 16:251–261. https://doi.org/10.1016/j.ebiom.2017.01.01910.1016/j.ebiom.2017.01.019 ↗
36. Elmore SE, Mitchell N, Mays T, Brown K, Marroquin-Cardona A, Romoser A, Phillips TD (2014) Common African cooking processes do not affect the aflatoxin binding efficacy of refined calcium montmorillonite clay. Food Control 37(1):27–32. https://doi.org/10.1016/j.foodcont.2013.08.03710.1016/j.foodcont.2013.08.037 ↗
37. Bettiol PS, Cechinel MAP, Oliveira CM, Goulart K, Dol-Bó AG, Bernardin AM, Peterson M (2022) Adsorption of aflatoxin B1 mycotoxins by raw and lyophilized bentonitic clay. Adv Powder Technol 33(8). https://doi.org/10.1016/j.apt.2022.10368210.1016/j.apt.2022.103682 ↗
38. Zhang N, Han X, Zhao Y, Li Y, Meng J, Zhang H, Liang J (2022) Removal of aflatoxin B1 and zearalenone by clay mineral materials: In the animal industry and environment. Appl Clay Sci 228:0–106614. https://doi.org/10.1016/j.clay.2022.10661410.1016/j.clay.2022.106614 ↗
39. Solhi L, Atai M, Nodehi A, Imani M, Ghaemi A, Khosravi K (2012) Poly(acrylic acid) grafted montmorillonite as novel fillers for dental adhesives: synthesis, characterization and properties of the adhesive. Dent Mater 28(4):369–377. https://doi.org/10.1016/j.dental.2011.11.01010.1016/j.dental.2011.11.010 ↗
40. Matsuo K, Yoshihara K, Nagaoka N, Makita Y, Obika H, Okihara T, … van Meerbeek B (2019) Rechargeable anti-microbial adhesive formulation containing cetylpyridinium chloride montmorillonite. Acta Biomaterialia 100:388–397. https://doi.org/10.1016/j.actbio.2019.09.04510.1016/j.actbio.2019.09.045 ↗
41. Kamari Y, Ghiaci P, Ghiaci M (2017) Study on montmorillonite/insulin/TiO2 hybrid nanocomposite as a new oral drug-delivery system. Mater Sci Eng, C 75:822–828. https://doi.org/10.1016/j.msec.2017.02.11510.1016/j.msec.2017.02.115 ↗
42. Akbal O, Vural T, Malekghasemi S, Bozdoğan B, Denkbaş EB (2018) Saponin loaded montmorillonite-human serum albumin nanocomposites as drug delivery system in colorectal cancer therapy. Appl Clay Sci 166:214–222. https://doi.org/10.1016/j.clay.2018.09.02110.1016/j.clay.2018.09.021 ↗
43. Bello ML, Aridio M, Vieira BA, Dias LRS, de Sousa VP, Castro HC, … Cabral LM (2015) Sodium montmorillonite/amine-containing drugs complexes: new insights on intercalated drugs arrangement into layered carrier material. PLoS One 10(3):1–20. https://doi.org/10.1371/journal.pone.012111010.1371/journal.pone.0121110 ↗
44. Kevadiya BD, Thumbar RP, Rajput MM, Rajkumar S, Brambhatt H, Joshi GV, … Bajaj HC (2012) Montmorillonite/poly-(-caprolactone) composites as versatile layered material: reservoirs for anticancer drug and controlled release property. Eur J Pharm Sci 47(1):265–272.https://doi.org/10.1016/j.ejps.2012.04.00910.1016/j.ejps.2012.04.009 ↗
45. Wang R, Peng Y, Zhou M, Shou D (2016) Smart montmorillonite-polypyrrole scaffolds for electro-responsive drug release. Appl Clay Sci 134:50–54. https://doi.org/10.1016/j.clay.2016.05.00410.1016/j.clay.2016.05.004 ↗
46. Jain S, Datta M (2015) Oral extended release of dexamethasone: montmorillonite-PLGA nanocomposites as a delivery vehicle. Appl Clay Sci 104:182–188. https://doi.org/10.1016/j.clay.2014.11.02810.1016/j.clay.2014.11.028 ↗
47. Rapacz-Kmita A, Bućko MM, Stodolak-Zych E, Mikołajczyk M, Dudek P, Trybus M (2017) Characterisation, in vitro release study, and antibacterial activity of montmorillonite-gentamicin complex material. Mater Sci Eng, C 70:471–478. https://doi.org/10.1016/j.msec.2016.09.03110.1016/j.msec.2016.09.031 ↗
48. Aguzzi C, Sandri G, Bonferoni C, Cerezo P, Rossi S, Ferrari F, … Viseras C (2014) Solid state characterisation of silver sulfadiazine loaded on montmorillonite/chitosan nanocomposite for wound healing. Colloids Surf B: Biointerfaces 113:152–157. https://doi.org/10.1016/j.colsurfb.2013.08.04310.1016/j.colsurfb.2013.08.043 ↗
49. Park JH, Shin HJ, Kim MH, Kim JS, Kang N, Lee JY, … Kim DD (2016) Application of montmorillonite in bentonite as a pharmaceutical excipient in drug delivery systems. J Pharm Investig. Springer Netherlands. https://doi.org/10.1007/s40005-016-0258-810.1007/s40005-016-0258-8 ↗
50. He H, Ma Y, Zhu J, Yuan P, Qing Y (2010) Applied clay science organoclays prepared from montmorillonites with different cation exchange capacity and surfactant con fi guration. Appl Clay Sci 48(1–2):67–72. https://doi.org/10.1016/j.clay.2009.11.02410.1016/j.clay.2009.11.024 ↗
51. Peng J, Yi H, Song S, Zhan W, Zhao Y (2019) Results in physics driving force for the swelling of montmorillonite as affected by surface charge and exchangeable cations : a molecular dynamic study. Results Phys 12(September 2018):113–117. https://doi.org/10.1016/j.rinp.2018.11.01110.1016/j.rinp.2018.11.011 ↗
52. França DB, Oliveira LS, Filho FGN, Filho ECS, Osajima JA, Jaber M, Fonseca MG (2022) The versatility of montmorillonite in water remediation using adsorption: current studies and challenges in drug removal. J Environ Chem Eng 10(2). https://doi.org/10.1016/j.jece.2022.10734110.1016/j.jece.2022.107341 ↗
53. Saadat S, Rawtani D, Parikh G (2022) Clay minerals-based drug delivery systems for anti-tuberculosis drugs. J Drug Deliv Sci Technol 76:103755. https://doi.org/10.1016/j.jddst.2022.10375510.1016/j.jddst.2022.103755 ↗
54. Yadav H, Agrawal R, Panday A, Patel J, Maiti S (2022) Polysaccharide-silicate composite hydrogels: review on synthesis and drug delivery credentials. J Drug Deliv Sci Technol 74:0–103573. https://doi.org/10.1016/j.jddst.2022.10357310.1016/j.jddst.2022.103573 ↗
55. Fellnhofer K (2019) Toward a taxonomy of entrepreneurship education research literature: a bibliometric mapping and visualization. Educ Res Rev 27:28–55. https://doi.org/10.1016/j.edurev.2018.10.00210.1016/j.edurev.2018.10.002 ↗
56. Zhu S, Liu Y, Gu Z, Zhao Y (2022) Research trends in biomedical applications of two-dimensional nanomaterials over the last decade – a bibliometric analysis. Adv Drug Deliv Rev 188:114420. https://doi.org/10.1016/j.addr.2022.11442010.1016/j.addr.2022.114420 ↗
57. Gusenbauer M, Haddaway NR (2020) Which academic search systems are suitable for systematic reviews or meta-analyses? Evaluating retrieval qualities of Google Scholar, PubMed, and 26 other resources. Res Synth Methods 11(2):181–217. https://doi.org/10.1002/jrsm.137810.1002/jrsm.1378 ↗
58. Zhao JF, Zou FL, Zhu JF, Huang C, Bu FQ, Zhu ZM, Yuan RF (2022) Nano-drug delivery system for pancreatic cancer: a visualization and bibliometric analysis. Front Pharmacol 13. https://doi.org/10.3389/fphar.2022.102561810.3389/fphar.2022.1025618 ↗
59. Navrot J, Banin A (1976) Comparison of modified montmorillonite to salts and chelates as carrier for micronutrients for plants: II Supply of iron. Agron J 68(2):358–361. https://doi.org/10.2134/AGRONJ1976.00021962006800020039X10.2134/AGRONJ1976.00021962006800020039X ↗
60. Mcginity JW, Harris MR (1980) Optimization of slow-release tablet formulations: containing montmorillonite I. Properties of tablets. Drug Dev Ind Pharm 6(4):399–410. https://doi.org/10.3109/0363904800906871110.3109/03639048009068711 ↗
61. Harris MR, Mcginity JW (1982) Optimization of slow-release tablet formulations containing montmorillonite II. Factors affecting drug release. Drug Dev Ind Pharm 8(6):783–793. https://doi.org/10.3109/0363904820902212410.3109/03639048209022124 ↗
62. Harris MR, Mcginity JW (1982) Optimization of slow-release tablet formulations containing montmorillonite III. Mechanism of release. Drug Dev Ind Pharm 8(6):795–809. https://doi.org/10.3109/0363904820902212510.3109/03639048209022125 ↗
63. Harris MR, Schwartz JB, Mcginity JW (1985) Optimization of a slow-release tablet formulation containing sodium sulfathiazole and a montmorillonite clay. Drug Dev Ind Pharm 11(5):1089–11. https://doi.org/10.3109/0363904850905559910.3109/03639048509055599 ↗
64. Choudary BM, Prabhu Prasad B, Lakshmi Kantam M (1989) New Interlamellar pesticide-Metal-montmorillonite complexes: a novel technique for controlled release. J Agric Food Chem 37:53. https://doi.org/10.1021/jf00089a04710.1021/jf00089a047 ↗
65. Saehr D, Walter D, Wey R (1991) Fixation de toluène dans une montmorillonite-Cu(II). Clay Miner 26(1):43–48. https://doi.org/10.1180/CLAYMIN.1991.026.1.0510.1180/CLAYMIN.1991.026.1.05 ↗
66. Al-Sabrl IYN, David Smith J, Thomas Donald J (1993) Molluscicides for control of Schistosomiasis. 3. Adsorption by clay suspensions. Environ Sci Technol 27(2):299–303.0013–936X/93/0927–0299$04.00/010.1021/es00039a009 ↗
67. Metwally AI, Mashhady AS, Falatah AM, Reda M (1993) Effect of pH on zinc adsorption and solubility in suspensions of different clays and soils. Zeitschrift für Pflanzenernährung und Bodenkunde 156(2):131–135. https://doi.org/10.1002/JPLN.1993156020610.1002/JPLN.19931560206 ↗
68. Lin FH, Lee YH, Jian CH, Wong J-M, Shieh M-J, Wang C-Y (2002) A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 23:1981–1987. https://doi.org/10.1016/S0142-9612(01)00325-810.1016/S0142-9612(01)00325-8 ↗
69. Lee W-F, Fu Y-T (2003) Effect of montmorillonite on the swelling behavior and drug-release behavior of nanocomposite hydrogels. J Appl Polym Sci 89:3652–366010.1002/app.12624 ↗
70. Kawase M, Hayashi Y, Kinoshita F, Yamato E, Miyazaki J, Yamakawa J, … Yagi K (2004) Protective effect of montmorillonite on plasmid DNA in oral gene delivery into small intestine. Biol Pharm Bull 27(12):2049–205110.1248/bpb.27.2049 ↗
71. Dong Y, Feng SS (2005) Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26(30):6068–6076. https://doi.org/10.1016/j.biomaterials.2005.03.02110.1016/j.biomaterials.2005.03.021 ↗
72. Chung AJ, Rubner MF (2002) Methods of loading and releasing low molecular weight cationic molecules in weak polyelectrolyte multilayer films. Langmuir 18(4):1176–1183. https://doi.org/10.1021/LA010873M10.1021/LA010873M ↗
73. Joshi GV, Kevadiya BD, Patel HA, Bajaj HC, Jasra RV (2009) Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int J Pharm 374(1–2):53–57. https://doi.org/10.1016/j.ijpharm.2009.03.00410.1016/j.ijpharm.2009.03.004 ↗
74. Patel HA, Somani RS, Bajaj HC, Jasra RV (2006) Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and waste water treatment. Bull Mater Sci 29(2):133–14510.1007/BF02704606 ↗
75. Carretero MI, Pozo M (2009) Clay and non-clay minerals in the pharmaceutical industry. Part I. Excipients and medical applications. Appl Clay Sci 46(1):73–80. https://doi.org/10.1016/j.clay.2009.07.01710.1016/j.clay.2009.07.017 ↗
76. Yuan Q, Shah J, Hein S, Misra RDK (2010) Controlled and extended drug release behavior of chitosan-based nanoparticle carrier. Acta Biomater 6(3):1140–1148. https://doi.org/10.1016/j.actbio.2009.08.02710.1016/j.actbio.2009.08.027 ↗
77. Wang X, Du Y, Luo J, Lin B, Kennedy JF (2007) Chitosan/organic rectorite nanocomposite films: structure, characteristic and drug delivery behaviour. Carbohyd Polym 69(1):41–49. https://doi.org/10.1016/j.carbpol.2006.08.02510.1016/j.carbpol.2006.08.025 ↗
78. Park JK, Choy YB, Oh JM, Kim JY, Hwang SJ, Choy JH (2008) Controlled release of donepezil intercalated in smectite clays. Int J Pharm 359(1–2):198–204. https://doi.org/10.1016/j.ijpharm.2008.04.01210.1016/j.ijpharm.2008.04.012 ↗
79. Depan D, Kumar AP, Singh RP (2009) Cell proliferation and controlled drug release studies of nanohybrids based on chitosan-g-lactic acid and montmorillonite. Acta Biomater 5(1):93–100. https://doi.org/10.1016/j.actbio.2008.08.00710.1016/j.actbio.2008.08.007 ↗
80. Aguzzi C, Cerezo P, Viseras C, Caramella C (2007) Use of clays as drug delivery systems: possibilities and limitations. Appl Clay Sci 36(1):22–36. https://doi.org/10.1016/j.clay.2006.06.01510.1016/j.clay.2006.06.015 ↗
81. Zheng JP, Luan L, Wang HY, Xi LF, Yao KD (2007) Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl Clay Sci 36(4):297–301. https://doi.org/10.1016/j.clay.2007.01.01210.1016/j.clay.2007.01.012 ↗
82. Wang X, Du Y, Luo J (2008) Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity. Nanotechnology 19(6). https://doi.org/10.1088/0957-4484/19/6/06570710.1088/0957-4484/19/6/065707 ↗
83. Joshi GV, Patel HA, Kevadiya BD, Bajaj HC (2009) Montmorillonite intercalated with vitamin B1 as drug carrier. Appl Clay Sci 45(4):248–253. https://doi.org/10.1016/j.clay.2009.06.00110.1016/j.clay.2009.06.001 ↗
84. Viseras C, Cerezo P, Sanchez R, Salcedo I, Aguzzi C (2010) Current challenges in clay minerals for drug delivery. Appl Clay Sci 48(3):291–295. https://doi.org/10.1016/j.clay.2010.01.00710.1016/j.clay.2010.01.007 ↗
85. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA (1983) Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–3510.1016/0378-5173(83)90064-9 ↗
86. Wang X, Li C, Wang Y, Chen H, Zhang X, Luo C, … Wang J (2022) Smart drug delivery systems for precise cancer therapy. Acta Pharmaceutica Sinica B 12(11):4098–4121. https://doi.org/10.1016/j.apsb.2022.08.01310.1016/j.apsb.2022.08.013 ↗
87. Moreno AE, Melchor L, Orts-Gil G, Gracia C, Lacunza I, Izquierdo B, Fernández-Vera JI (2017) Spanish science diplomacy: a global and collaborative bottom-up approach. Science & Diplomacy, 6, 1–12. Retrieved from http://www.sciencediplomacy.org/article/2017/spanish-science-diplomacy-global-and-collaborative-bottom-approach
88. Zhou CH, Zhao LZ, Wang AQ, Chen TH, He HP (2016) Current fundamental and applied research into clay minerals in China. Appl Clay Sci 119:3–7. https://doi.org/10.1016/j.clay.2015.07.04310.1016/j.clay.2015.07.043 ↗
89. Manoharan C, Sutharsan P, Dhanapandian S, Venkatachalapathy R (2012) Characteristics of some clay materials from Tamilnadu, India, and their possible ceramic uses. Cerâmica 58:412–41810.1590/S0366-69132012000300021 ↗
90. Cheng K, Guo Q, Yang W, Wang Y, Sun Z, Wu H (2022) Mapping knowledge landscapes and emerging trends of the links between bone metabolism and diabetes mellitus: a bibliometric analysis from 2000 to 2021. Front Public Health 10. https://doi.org/10.3389/fpubh.2022.91848310.3389/fpubh.2022.918483 ↗
91. Marx Z, Dagan I, Buhmann JM, Shamir E, Shamir Shamir E, Brodley CE, Danyluk A (2002) Coupled clustering: a method for detecting structural correspondence Zvika Marx Ido Dagan. J Mach Learn Res 3:747–780
92. Cabrera A, Celis R, Hermosín MC (2016) Imazamox-clay complexes with chitosan-and iron(III)-modified smectites and their use in nanoformulations. Pest Manag Sci 72:1285–1294. https://doi.org/10.1002/ps.410610.1002/ps.4106 ↗
93. Phuekphong AF, Imwiset KJ, Ogawa M (2020) Designing nanoarchitecture for environmental remediation based on the clay minerals as building block. J Hazard Mater 399:122888. https://doi.org/10.1016/J.JHAZMAT.2020.12288810.1016/J.JHAZMAT.2020.122888 ↗
94. Zhang H, Shi Y, Xu X, Zhang M, Ma L (2020) Structure regulation of bentonite-alginate nanocomposites for controlled release of imidacloprid. ACS Omega. https://doi.org/10.1021/acsomega.0c0061010.1021/acsomega.0c00610 ↗
95. Chevillard A, Angellier-Coussy H, Guillard V, Gontard N, Gastaldi E (2012) Controlling pesticide release via structuring agropolymer and nanoclays based materials. J Hazard Mater 205–206:32–39. https://doi.org/10.1016/j.jhazmat.2011.11.09310.1016/j.jhazmat.2011.11.093 ↗
96. Jiang L, Mo J, Kong Z, Qin Y, Dai L, Wang Y, Ma L (2015) Effects of organobentonites on imidacloprid release from alginate-based formulation. Appl Clay Sci 105–106:52–59. https://doi.org/10.1016/J.CLAY.2014.12.02310.1016/J.CLAY.2014.12.023 ↗
97. Wu C, Lou X, Xu X, Huang A, Zhang M, Ma L (2020) Thermodynamics and kinetics of pretilachlor adsorption on organobentonites for controlled release. ACS Omega 5(8):4191–4199. https://doi.org/10.1021/acsomega.9b0402510.1021/acsomega.9b04025 ↗
98. Wu C, Lou X, Huang A, Zhang M, Ma L (2020) Thermodynamics and kinetics of pretilachlor adsorption: implication to controlled release from organobentonites. Appl Clay Sci 190. https://doi.org/10.1016/j.clay.2020.10556610.1016/j.clay.2020.105566 ↗
99. Mo J, Dai L, Chen L, Wang Y, Huang A, Wang L, Ma L (2015) Structural effects of organobentonites on controlled release of pretilachlor. Appl Clay Sci 115:150–156. https://doi.org/10.1016/j.clay.2015.07.03610.1016/j.clay.2015.07.036 ↗
100. Chevillard A, Angellier-Coussy H, Peyron S, Gontard N, Gastaldi E (2012) Investigating ethofumesate-clay interactions for pesticide controlled release. Soil Sci Soc Am J 76(2):420–431. https://doi.org/10.2136/sssaj2011.010410.2136/sssaj2011.0104 ↗